Article info

PDF

Human glioma cells transformed by IGF-I triple helix technology show immune and apoptotic characteristics determining cell selection for gene therapy of glioblastoma
  1. Dr Trojan, Lab. Neurologie du Développement, INSERM E9935& Univ. Paris VII, Hôpital Robert Debré, 48, Bd. Sérurier, 75019 Paris, France JerzyTrojan{at}compuserve.com
View Full Text

Citation

Ly A, Duc HT, Kalamarides M, et al
Human glioma cells transformed by IGF-I triple helix technology show immune and apoptotic characteristics determining cell selection for gene therapy of glioblastoma

Publication history

  • Accepted 8 March 2001
  • Published online 1 August 2001.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.